EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

SF3B1 thermostability as an assay for splicing inhibitor interactions

Angela N Amorello, Guddeti Chandrashekar Reddy, Bruno Melillo, Benjamin F Cravatt, Arun K Ghosh, Melissa S Jurica

Journal of Biological Chemistry · 2025-02 · 301 (2) · 108135

DOI: 10.1016/j.jbc.2024.108135 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2025-02. Verfasst von Angela N Amorello und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of California, Santa Cruz, California, USA. Hauptthemen laut MEDLINE: RNA Splicing Factors, Phosphoproteins, RNA Splicing, Ribonucleoprotein, U2 Small Nuclear. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, NIGMS NIH HHS, National Institutes of Health National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The spliceosome protein, SF3B1, is associated with U2 snRNP during early spliceosome assembly for pre-mRNA splicing. Frequent somatic mutations in SF3B1 observed in cancer necessitates the characterization of its role in identifying the branchpoint adenosine of introns. Remarkably, SF3B1 is the target of three distinct natural product drugs, each identified by their potent anti-tumor properties. Structural studies indicate that SF3B1 conformational flexibility is functionally important, and suggest that drug binding blocks the transition to a closed state of SF3B1 required for the next stage of spliceosome assembly. This model is confounded, however, by the antagonistic property of an inactive herboxidiene analog. In this study, we established an assay for evaluating the thermostability of SF3B1 present in the nuclear extract preparations employed for in vitro splicing studies, to investigate inhibitor interactions with SF3B1 in a functional context. We show that both active and antagonistic analogs of natural product inhibitors affect SF3B1 thermostability, consistent with binding alone being insufficient to impair SF3B1 function. Surprisingly, SF3B1 thermostability differs among nuclear extract preparations, likely reflecting its conformational status. We also investigated a synthetic SF3B1 ligand, WX-02-23, and found that it increases SF3B1 thermostability and interferes with in vitro splicing by a mechanism that strongly resembles the activity of natural product inhibitors. We propose that altered SF3B1 thermostability can serve as an indicator of inhibitor binding to complement functional assays of their general effect on splicing. It may also provide a means to investigate the factors that influence SF3B1 conformation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA Splicing FactorsPhosphoproteinsRNA SplicingRibonucleoprotein, U2 Small NuclearHumansProtein StabilitySpliceosomesPyransFuransFatty Alcohols

Stichwörter der Autor:innen

RNA splicingSF3B1conformational changeinhibition mechanismnatural productspliceosomesplicing inhibitorthermal shift assay

Substanzen

RNA Splicing FactorsSF3B1 protein, humanPhosphoproteinsPyransherboxidieneFuransRibonucleoprotein, U2 Small NuclearFatty Alcohols

Autor:innen und Institutionen

  • Department of Chemistry and Biochemistry, University of California, Santa Cruz, California, USA.
  • Department of Chemistry and Department of Medicinal Chemistry, Purdue University, West Lafayette, Indiana, USA.
  • Department of Chemistry, Scripps Research, La Jolla, California, USA.
  • Department of Molecular Cell and Developmental Biology, University of California, Santa Cruz, California, USA; Center for Molecular Biology of RNA, University of California, Santa Cruz, California, USA. Electronic addre…

Förderung

  • NCI NIH HHS
  • NIGMS NIH HHS
  • National Institutes of Health National Cancer Institute
  • National Institutes of Health
  • National Institute of General Medical Sciences

Zitieren

APA

Amorello, A. N., Chandrashekar Reddy, G., Melillo, B., Cravatt, B. F., Ghosh, A. K., & Jurica, M. S. (2025). SF3B1 thermostability as an assay for splicing inhibitor interactions. Journal of Biological Chemistry, 301(2), 108135. https://doi.org/10.1016/j.jbc.2024.108135

Vancouver

Amorello AN, Chandrashekar Reddy G, Melillo B, Cravatt BF, Ghosh AK, Jurica MS. SF3B1 thermostability as an assay for splicing inhibitor interactions. Journal of Biological Chemistry. 2025;301(2):108135. doi:10.1016/j.jbc.2024.108135

BibTeX
@article{Amorello2025,
  author = {Amorello, Angela N and Chandrashekar Reddy, Guddeti and Melillo, Bruno and Cravatt, Benjamin F and Ghosh, Arun K and Jurica, Melissa S},
  title = {SF3B1 thermostability as an assay for splicing inhibitor interactions},
  journal = {Journal of Biological Chemistry},
  year = {2025},
  volume = {301},
  number = {2},
  pages = {108135},
  doi = {10.1016/j.jbc.2024.108135}
}
Kostenlos starten →